AstraZeneca PLC ADR (AZNPy)

63.400
-0.800(-1.25%)
  • Volume:
    0
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    63.400 - 63.400

AZNPy Comments

What is your sentiment on AstraZeneca ADR?
or
Market is currently closed. Voting is open during market hours.

All Comments

(499)
  • did they develop a vaccine that works now or why is thos going up?
    0
    • Valneva
      0
      • why this trash going up?
        3
        • speculation
          0
      • already breakout guy.
        0
        • I would await some further drop based on the below article to come in the near future. The company did not perform well with the vaccine and i opened some short positions if my assumptions are correct.
          0
          • https://moneyweek.com/investments/stocks-and-shares/biotech-stocks/603675/astrazenecas-covid-troubles-could-see-it-pull
            0
            • hold long = big victory ✌
              0
              • Finally it reached $60+.
                0
                • AZN and MRK: Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Support is strong for the 2 stocks.
                  0
                  • the Delta virus already in USA, but the CDC covered up the truth. in this next 2 weeks, millions of people will get infected, many states may lockdown again.
                    1
                    • Forget about AZN vaccines, they product it at no profit. The Company continues to engage with governments, international organisations and collaborators around the world to ensure broad and equitable access to this well-tolerated and effective vaccine at no profit during the pandemic period.
                      0
                      • The company has been doing a great job so far this year, will continue making profit from COVID-19 vaccines and many other drugs.
                        0
                        • Good news, AstraZeneca said the EU had lost its legal case, the company will deliver vaccines to EU.
                          0
                          • Wow, look at the hug volume, the long awaited $60 to come next week.
                            0
                            • the beginning of the end . the train pulls down.
                              0
                              • CBC News Canada: As per The National Advisory Committee on Immunization (NACI) in Canada announced, the people who took 1st dose of AstraZenaca, as 2nd dose they will take Pfizer-BioNTech COVID-19 Vaccine, or Moderna. Since early May, all provinces have halted the use of AstraZeneca for first doses.
                                0
                                • MOSCOW, June 17 (Reuters) - Moscow is facing a new coronavirus variant that is more aggressive and infectious, and the situation in the city is rapidly deteriorating, Moscow mayor, Sergei Sobyanin said.A new mutation has arrived, a new strain is active. It's more aggressive, it's harder to recover from, it spreads faster. It's much more likely to penetrate a person's immune system," Sobyanin said, according to the RIA news agency.
                                  0
                                  • EU to decide on Astrazeneca's $39 billion Alexion deal by July 5
                                    1
                                    • Once EU approves the deal, AZN will have 5 more profitable drugs to sell worldwide.
                                      1
                                  • AZN vaccines work very well in India and Japan .
                                    1
                                    • AZN Vaccine halted in Italy due to a teenager’s death.
                                      0
                                      • UK study finds AZN vaccines offer 92% protection against hospitalisation from Delta variant
                                        1
                                        • Look at the Gaps, enjoy the speed.
                                          1
                                          • let's go baby, up up & away
                                            1
                                            • all vaccines are effective, experts point out that their efficacy wanes over time, and a booster dose may be needed every year. The company will make profits from Covid-19 vaccines every year.
                                              2
                                              • There is global shortage of coronavirus vaccines, WHO approved AZN vaccine for Emergency Use.
                                                1
                                                • We need to trust scientists, US government and WHO.
                                                  3